Literature DB >> 17251342

Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening.

Marcin P Kaczor1, Marek Sanak, Andrew Szczeklik.   

Abstract

alpha(1)-Antitrypsin (AAT) deficiency is one of the most common genetic disorders in Caucasians, leading to early onset pulmonary emphysema and/or liver disorders. Accumulating data suggest that AAT deficiency is commonly under-recognized or misdiagnosed by physicians. The need for a rapid, timesaving, and relatively inexpensive but reliable detection method for the two most common deficiency alleles was developed using real-time polymerase chain reaction (PCR) genotyping. We designed and validated a 5'-nuclease assay for typing of the PI*S and PI*Z alleles using dual-labeled target-specific fluorescent probes. As a reference method, we used restriction fragment length polymorphism. The real-time PCR method was tested on a large, cross-sectional epidemiological trial. Overall, we genotyped about 1200 samples and found a very good concordance with AAT serum levels and restriction fragment length polymorphism results. In addition, external interlaboratory validation confirmed the accuracy of the real-time PCR method. In our experience, the real-time qualitative PCR using 5'-nuclease assay is suitable as a genetic test for AAT deficiency. This method offers an acceptable balance between reliability and expenses. It seems appropriate for both population-based screening and clinical diagnosis of the deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251342      PMCID: PMC1867421          DOI: 10.2353/jmoldx.2007.060048

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  29 in total

1.  Rapid analysis of alpha1-antitrypsin PiZ genotype by a real-time PCR approach.

Authors:  M E Ortiz-Pallardó; H Zhou; H P Fischer; T Neuhaus; A Sachinidis; H Vetter; T Brüning; Y Ko
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 2.  Alpha1-antitrypsin deficiency--a model for conformational diseases.

Authors:  Robin W Carrell; David A Lomas
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

3.  Distribution of alpha1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis.

Authors:  I Blanco; E F Bustillo; M C Rodriguez
Journal:  Clin Genet       Date:  2001-12       Impact factor: 4.438

4.  Use of two reporter dyes without interference in a single-tube rapid-cycle PCR: alpha(1)-antitrypsin genotyping by multiplex real-time fluorescence PCR with the LightCycler.

Authors:  N von Ahsen; M Oellerich; E Schütz
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

5.  American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-10-01       Impact factor: 21.405

Review 6.  Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

Authors:  Frederick J de Serres
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

7.  Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys.

Authors:  I Blanco; E Fernández; E F Bustillo
Journal:  Clin Genet       Date:  2001-07       Impact factor: 4.438

8.  Genomic DNA extraction from small amounts of serum to be used for alpha1-antitrypsin genotype analysis.

Authors:  S Andolfatto; F Namour; A L Garnier; F Chabot; J L Gueant; I Aimone-Gastin
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

9.  Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.

Authors:  F J de Serres; I Blanco; E Fernández-Bustillo
Journal:  Clin Genet       Date:  2003-11       Impact factor: 4.438

Review 10.  Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.

Authors:  Frederick J de Serres
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

View more
  5 in total

1.  Alpha-1 antitrypsin phenotypes in patients with Klinefelter's syndrome.

Authors:  Ruth Mikelsaar; Jelena Lissitsina; Kristo Ausmees; Margus Punab; Paul Korrovits; Eve Vaidla
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.

Authors:  Irene Belmonte; Miriam Barrecheguren; Rosa M López-Martínez; Cristina Esquinas; Esther Rodríguez; Marc Miravitlles; Francisco Rodríguez-Frías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-11

3.  Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.

Authors:  Noura Al-Jameil; Amina A Hassan; Ahlam Buhairan; Rana Hassanato; Sree R Isac; Maram Al-Otaiby; Basmah Al-Maarik; Iman Al-Ajeyan
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  Alpha1-antitrypsin deficiency: a clinical-genetic overview.

Authors:  Raja T Abboud; Tanya N Nelson; Benjamin Jung; Andre Mattman
Journal:  Appl Clin Genet       Date:  2011-03-31

5.  Alpha 1 antitrypsin deficiency in infants with neonatal cholestasis.

Authors:  Maryam Monajemzadeh; Reza Shahsiah; Mohammad Vasei; Parin Tanzifi; Nima Rezaei; Mehri Najafi; Narjes Soleimanifar; Maryam Eghbali
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.